These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34172515)

  • 21. Enhanced interaction between natural killer cells and lung cancer cells: involvement in gefitinib-mediated immunoregulation.
    He S; Yin T; Li D; Gao X; Wan Y; Ma X; Ye T; Guo F; Sun J; Lin Z; Wang Y
    J Transl Med; 2013 Aug; 11():186. PubMed ID: 23937717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The two-faces of NK cells in oncolytic virotherapy.
    Marotel M; Hasim MS; Hagerman A; Ardolino M
    Cytokine Growth Factor Rev; 2020 Dec; 56():59-68. PubMed ID: 32586674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C; Lopez C
    J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential In Vitro Growth and Cell Killing of Cancer versus Benign Prostate Cells by Oncolytic Parainfluenza Virus.
    Kedarinath K; Parks GD
    Pathogens; 2022 Apr; 11(5):. PubMed ID: 35631014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions.
    Garcia-Iglesias T; Del Toro-Arreola A; Albarran-Somoza B; Del Toro-Arreola S; Sanchez-Hernandez PE; Ramirez-Dueñas MG; Balderas-Peña LM; Bravo-Cuellar A; Ortiz-Lazareno PC; Daneri-Navarro A
    BMC Cancer; 2009 Jun; 9():186. PubMed ID: 19531227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-Infected Macrophages Are Infected and Killed by the Interferon-Sensitive Rhabdovirus MG1.
    Sandstrom TS; Ranganath N; Burke Schinkel SC; Salahuddin S; Meziane O; Côté SC; Costiniuk CT; Jenabian MA; Angel JB
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33568507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The histone deacetylase inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells by inhibition of STAT5/T-BET signaling and generation of gamma interferon.
    Alvarez-Breckenridge CA; Yu J; Price R; Wei M; Wang Y; Nowicki MO; Ha YP; Bergin S; Hwang C; Fernandez SA; Kaur B; Caligiuri MA; Chiocca EA
    J Virol; 2012 Apr; 86(8):4566-77. PubMed ID: 22318143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PM21-particle stimulation augmented with cytokines enhances NK cell expansion and confers memory-like characteristics with enhanced survival.
    Oyer JL; Croom-Perez TJ; Hasan MF; Rivera-Huertas JA; Gitto SB; Mucha JM; Zhu X; Altomare DA; Igarashi RY; Copik AJ
    Front Immunol; 2024; 15():1383281. PubMed ID: 38711506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physical Characterization of Colorectal Cancer Spheroids and Evaluation of NK Cell Infiltration Through a Flow-Based Analysis.
    Sargenti A; Musmeci F; Bacchi F; Delprete C; Cristaldi DA; Cannas F; Bonetti S; Pasqua S; Gazzola D; Costa D; Villa F; Zocchi MR; Poggi A
    Front Immunol; 2020; 11():564887. PubMed ID: 33424829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.
    Moretta A; Bottino C; Vitale M; Pende D; Cantoni C; Mingari MC; Biassoni R; Moretta L
    Annu Rev Immunol; 2001; 19():197-223. PubMed ID: 11244035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency.
    Li F; Sheng Y; Hou W; Sampath P; Byrd D; Thorne S; Zhang Y
    J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32098828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer.
    van Vloten JP; Matuszewska K; Minow MAA; Minott JA; Santry LA; Pereira M; Stegelmeier AA; McAusland TM; Klafuric EM; Karimi K; Colasanti J; McFadden DG; Petrik JJ; Bridle BW; Wootton SK
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35296558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model.
    Swift BE; Williams BA; Kosaka Y; Wang XH; Medin JA; Viswanathan S; Martinez-Lopez J; Keating A
    Haematologica; 2012 Jul; 97(7):1020-8. PubMed ID: 22271890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence of interferon production in the hamster lung after primary or secondary exposure to parainfluenza virus type 3.
    Harmon AT; Harmon MW; Glezen WP
    Am Rev Respir Dis; 1982 Jun; 125(6):706-11. PubMed ID: 6178328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural Killer Cells Recruitment in Oncolytic Virotherapy: A Mathematical Model.
    Senekal NS; Mahasa KJ; Eladdadi A; de Pillis L; Ouifki R
    Bull Math Biol; 2021 May; 83(7):75. PubMed ID: 34008149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mast Cells and Natural Killer Cells-A Potentially Critical Interaction.
    Portales-Cervantes L; Dawod B; Marshall JS
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31167464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NKp46.
    Mandelboim O; Porgador A
    Int J Biochem Cell Biol; 2001 Dec; 33(12):1147-50. PubMed ID: 11606250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early responses of natural killer cells in pigs experimentally infected with 2009 pandemic H1N1 influenza A virus.
    Forberg H; Hauge AG; Valheim M; Garcon F; Nunez A; Gerner W; Mair KH; Graham SP; Brookes SM; Storset AK
    PLoS One; 2014; 9(6):e100619. PubMed ID: 24955764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus.
    Kirn DH; Wang Y; Le Boeuf F; Bell J; Thorne SH
    PLoS Med; 2007 Dec; 4(12):e353. PubMed ID: 18162040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging role of Natural killer cells in oncolytic virotherapy.
    Bhat R; Rommelaere J
    Immunotargets Ther; 2015; 4():65-77. PubMed ID: 27471713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.